Navigator-Assisted Hypofractionation (NAVAH) on Radiation Therapy Completion in Breast Cancer and Prostate Cancer

Not yet recruitingOBSERVATIONAL
Enrollment

420

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

September 30, 2029

Study Completion Date

September 30, 2030

Conditions
Breast CancerProstate Cancer
Interventions
OTHER

Pre & Post Surveys

As part of this intervention, patients will complete a pre-treatment questionnaire at the time of consent, which can be administered in person, over the phone, or through the mHealth mobile app, based on their preference. One month after treatment, patients will complete a post-treatment questionnaire using their chosen method. At the six-month mark, patients will complete an additional post-treatment questionnaire along with the COST-Functional Assessment of Chronic Illness Therapy (COST-FACT) survey.

OTHER

Opt Out of Questionnaire

As part of this intervention, patients declined to participate in the optional questionnaire. However, their data will still be collected through chart review and will be compared to the data of patients who accepted both the questionnaire and navigation services.

Trial Locations (1)

73117

OU Health Stephenson Cancer Center, Oklahoma City

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Gilead Sciences

INDUSTRY

collaborator

Radiation Therapy Oncology Group

NETWORK

collaborator

Susan G. Komen Breast Cancer Foundation

OTHER

lead

University of Oklahoma

OTHER